HLVX HilleVax Inc: Accounting Value per Share

Graphic logo of HilleVax, Inc. (HLVX)

The actual book value per share on this GURU.Markets platform chart shows that 2.95 is the current level of the indicator. HilleVax, Inc. (HLVX) has its contractual capacities fully utilized in preparing drugs for final testing. A global network of bio-warehouses minimizes the risks of serum spoilage, ensuring supply stability. The development of a unique norovirus vaccine opens colossal market prospects for the company.

HilleVax Inc (HLVX): Share Book Value from 06/21/2023 to 09/27/2025

hillevax.com - analytical breakdowns and key metrics (HLVX)

- price and consensus price forecast:
Stock Quotes HilleVax Corp|HLVX - Price Target Chart
- market capitalization data:
Market Valuation HilleVax, Inc.|HLVX - Business Value
- book capitalization data:
Net Assets per Single Share HilleVax|HLVX - Net Asset Value|Market Capitalization to Book Value Ratio hillevax.com|HLVX - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital HilleVax, Inc.|HLVX - Long-Term Debt to Capital|Short-Term Debt to Equity HilleVax|HLVX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio HilleVax, Inc.|HLVX - Company Long-Term Liabilities|Company Short-Term Debts HilleVax
Fundamental company valuation:HilleVax Corp - HLVX
Manufactured products of HilleVax

This indicator reflects the net asset value per share, serving as a filter to separate real capitalization from speculative market expectations. By analyzing the book value per share curve, an investor assesses the financial stability of HilleVax, Inc. (HLVX), where accumulated capital supports the development of a closed patent perimeter and the expansion of exclusive norovirus prevention programs within the pediatric segment.

Competitors of HilleVax, Inc. (HLVX)

GILD - Accounting Value per Share|Cidara Therapeutics Corp (CDTX) - Net Assets per Single Share|Accounting Value per Share Novavax, Inc.|CVAC (curevac.com) - Equity per Share|Net Assets per Single Share Valneva VALN|Share Book Value Vir Biotechnology Inc|SIGA Corp (SIGA) - Book Value per Share|Accounting Value of a Share Emergent Bio (EBS)|Book Value per Share AVIR (Atea Pharmaceuticals)|Invivyd Inc - Book Value per Share|Net Assets per Single Share Enanta Pharmaceuticals, Inc. (ENTA)|INO: Accounting Value of a Share|KLRS (Kalaris Therapeutics, Inc.) - Net Assets per Single Share|Dyadic International, Inc. (DYAI) - Accounting Value per Share|NNVC (NanoViricides Inc.) - Book Value per Share|Book Value per Share talphera.com (TLPH)|Cocrystal Pharma (COCP) - Accounting Value per Share|Accounting Value of a Share trawspharma.com TRAW|Accounting Value per Share Dogwood Therapeutics DWTX|Net Assets per Single Share Qualigen Corp QLGN|Book Value per Share ALVR (AlloVir Bio)|VBIV: Net Assets per Share|Net Assets per Single Share virios.com VIRI|Accounting Value of a Share Vaxart